As financial leaders prepare for 2025, efficiency and transparency remain key organizational priorities, particularly in expense management. Acquis SAP Concur Consultants offer insights on leveraging Concur expense reporting to enhance productivity and visibility.  

The rise of artificial intelligence continues to transform the pharmaceutical industry, offering solutions to longstanding challenges across the value chain. As pharmaceutical companies embrace this technological revolution, organizations are implementing AI use cases that tackle critical issues in drug discovery, clinical trial development, and patient monitoring, opening doors to innovative approaches in pharmaceutical research and development. 

Precision medicine, or personalized medicine, has moved from niche to mainstream. Companies continue to place larger bets on its transformative impact to create unprecedented patient outcomes. While precision medicine offers significant market opportunities, the traditional models for drug development no longer apply, creating new complexities. Precision medicine requires more nuanced clinical trial designs, complex data infrastructure, and novel market access strategies due to its highly targeted therapies and smaller patient populations.

The rapid proliferation of artificial intelligence (AI) created a veritable alphabet soup – GenAI, GPT, LLMs, NLP, and much more. The jargon can be overwhelming, causing many enterprise leaders to waffle when deciding how to pilot and accelerate AI. AI models like generative pre-trained transformers (GPT) have become imperative for businesses aiming to stay competitive. Understanding the factors that influence this decision is crucial for business leaders seeking to harness the power of AI — especially Generative AI. 

Once an investor opts to invest into a business, there are myriad legal considerations. What vehicle will the investor use? What instrument will the company use to trade equity for capital?

Part two of From Vision to Venture explores how companies can demonstrate product-market fit. It reviews how to effectively prove value while connecting to an investor’s thesis to secure capital.

Raising investment capital is a critical activity in the lifecycle of a business, and securing funding is a multi-stage, iterative process. Delivering an effective pitch is like telling a story. It starts with a hook that grabs the audience’s attention before going into the background and main arc.

The clinical trial landscape is transforming and pivoting away from its reliance on data collection within the confines of traditional research facilities.